334 related articles for article (PubMed ID: 33492286)
1. Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.
Grober E; Qi Q; Kuo L; Hassenstab J; Perrin RJ; Lipton RB
J Alzheimers Dis; 2021; 80(1):185-195. PubMed ID: 33492286
[TBL] [Abstract][Full Text] [Related]
2. The Free and Cued Selective Reminding Test Predicts Braak Stage.
Grober E; Qi Q; Kuo L; Hassenstab J; Perrin RJ; Lipton RB
J Alzheimers Dis; 2021; 80(1):175-183. PubMed ID: 33492287
[TBL] [Abstract][Full Text] [Related]
3. Association of Stages of Objective Memory Impairment With Incident Symptomatic Cognitive Impairment in Cognitively Normal Individuals.
Grober E; Petersen KK; Lipton RB; Hassenstab J; Morris JC; Gordon BA; Ezzati A
Neurology; 2023 May; 100(22):e2279-e2289. PubMed ID: 37076305
[TBL] [Abstract][Full Text] [Related]
4. Psychometric Properties of the Clinical Dementia Rating - Sum of Boxes and Other Cognitive and Functional Outcomes in a Prodromal Alzheimer's Disease Population.
McDougall F; Edgar C; Mertes M; Delmar P; Fontoura P; Abi-Saab D; Lansdall CJ; Boada M; Doody R
J Prev Alzheimers Dis; 2021; 8(2):151-160. PubMed ID: 33569561
[TBL] [Abstract][Full Text] [Related]
5. The Use of Episodic Memory Tests for Screening in Clinical Trials for Early Alzheimer's Disease: A Comparison of the Free and Cued Selective Reminding Test (FCSRT) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).
Teng E; Manser PT; Shah M; Pickthorn K; Hu N; Djakovic S; Swendsen H; Blendstrup M; Faccin G; Ostrowitzki S; Sink KM
J Prev Alzheimers Dis; 2023; 10(1):41-49. PubMed ID: 36641609
[TBL] [Abstract][Full Text] [Related]
6. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
[TBL] [Abstract][Full Text] [Related]
7. Validity of the Clinical Dementia Rating Scale Sum of Boxes in Staging and Detection of Cognitive Impairment in Mexican Americans.
Julayanont P; DeToledo JC
J Geriatr Psychiatry Neurol; 2022 Jan; 35(1):128-134. PubMed ID: 33261535
[TBL] [Abstract][Full Text] [Related]
8. The SIST-M: predictive validity of a brief structured clinical dementia rating interview.
Okereke OI; Pantoja-Galicia N; Copeland M; Hyman BT; Wanggaard T; Albert MS; Betensky RA; Blacker D
Alzheimer Dis Assoc Disord; 2012; 26(3):225-31. PubMed ID: 21986342
[TBL] [Abstract][Full Text] [Related]
9. Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database.
O'Bryant SE; Lacritz LH; Hall J; Waring SC; Chan W; Khodr ZG; Massman PJ; Hobson V; Cullum CM
Arch Neurol; 2010 Jun; 67(6):746-9. PubMed ID: 20558394
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
[TBL] [Abstract][Full Text] [Related]
11. Neurofibrillary Tangle Stage and the Rate of Progression of Alzheimer Symptoms: Modeling Using an Autopsy Cohort and Application to Clinical Trial Design.
Qian J; Hyman BT; Betensky RA
JAMA Neurol; 2017 May; 74(5):540-548. PubMed ID: 28288263
[TBL] [Abstract][Full Text] [Related]
12. Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study.
Peterson D; Munger C; Crowley J; Corcoran C; Cruchaga C; Goate AM; Norton MC; Green RC; Munger RG; Breitner JC; Welsh-Bohmer KA; Lyketsos C; Tschanz J; Kauwe JS;
Alzheimers Dement; 2014 May; 10(3):366-71. PubMed ID: 23727081
[TBL] [Abstract][Full Text] [Related]
13. Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer's Disease.
Malek-Ahmadi M; Perez SE; Chen K; Mufson EJ
J Alzheimers Dis; 2020; 74(1):189-197. PubMed ID: 31985469
[TBL] [Abstract][Full Text] [Related]
14. Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease.
Papp KV; Amariglio RE; Mormino EC; Hedden T; Dekhytar M; Johnson KA; Sperling RA; Rentz DM
Neuropsychologia; 2015 Jul; 73():169-75. PubMed ID: 26002757
[TBL] [Abstract][Full Text] [Related]
15. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.
Dickerson BC; Sperling RA; Hyman BT; Albert MS; Blacker D
Arch Gen Psychiatry; 2007 Dec; 64(12):1443-50. PubMed ID: 18056553
[TBL] [Abstract][Full Text] [Related]
16. Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging.
Beach TG; Sue LI; Walker DG; Sabbagh MN; Serrano G; Dugger BN; Mariner M; Yantos K; Henry-Watson J; Chiarolanza G; Hidalgo JA; Souders L
J Alzheimers Dis; 2012; 28(4):869-76. PubMed ID: 22112552
[TBL] [Abstract][Full Text] [Related]
17. Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study.
Grober E; Lipton RB; Sperling RA; Papp KV; Johnson KA; Rentz DM; Veroff AE; Aisen PS; Ezzati A
Neurology; 2022 Mar; 98(13):e1327-e1336. PubMed ID: 35197359
[TBL] [Abstract][Full Text] [Related]
18. Detecting Treatment Group Differences in Alzheimer's Disease Clinical Trials: A Comparison of Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB).
Wessels AM; Dowsett SA; Sims JR
J Prev Alzheimers Dis; 2018; 5(1):15-20. PubMed ID: 29405227
[TBL] [Abstract][Full Text] [Related]
19. Identification of Alzheimer and vascular lesion thresholds for mixed dementia.
Gold G; Giannakopoulos P; Herrmann FR; Bouras C; Kövari E
Brain; 2007 Nov; 130(Pt 11):2830-6. PubMed ID: 17878206
[TBL] [Abstract][Full Text] [Related]
20. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
